The clinical significance of paroxysmal atrial fibrillation detected after stroke
10.3969/j.issn.1002-0152.2025.06.008
- VernacularTitle:卒中后新发阵发性房颤的临床意义
- Author:
Lisi ZHA
1
;
Xiya LONG
1
;
Jinsheng ZENG
1
Author Information
1. 中山大学附属第一医院神经科,广东省重大神经疾病诊治研究重点实验室,国家临床重点专科和国家重点学科(广州 510080)
- Publication Type:Journal Article
- Keywords:
Stroke;
Paroxysmal atrial fibrillation;
Prognosis;
Diagnosis;
Medication;
Anticoagulation therapy;
Secondary prevention
- From:
Chinese Journal of Nervous and Mental Diseases
2025;51(6):370-374
- CountryChina
- Language:Chinese
-
Abstract:
Atrial fibrillation(AF)is a major risk factor for stroke,exerting a significant influence on stroke progression and prognosis.Paroxysmal atrial fibrillation detected after stroke(PAFDAS)has attracted considerable attention due to its key role in stroke onset,progression,and recurrence.Studies show that extending the duration of electrocardiographic monitoring can increase detection rate of PAFDAS.Compared to patients with known atrial fibrillation before stroke,those with PAFDAS exhibit better clinical outcomes,including lower risks of bleeding and mortality.However,there still remains controversy regarding anticoagulant therapy for secondary prevention in PAFDAS patients.Current evidence indicates that with regard to clinical outcomes,anticoagulant drugs does not demonstrate significant superiority over antiplatelet drugs,while concurrently posing an elevated risk of bleeding complications.Consequently,further research is warranted to establish optimal preventive strategies.This review focuses on examining the diagnostic criteria,analyzing the advantages and limitations of each electrocardiographic monitoring session,discussing the clinical outcomes of PAFDAS,with the goal of enhancing clinical recognition of PAFDAS.
